[1] Moncada S., Gryglewski R., Bunting S., Vane J. R., Nature, 1976, 263, 663
[2] Wakita H., Yoshiwara H., Tajima A., Kitano Y., Nagase H., Tetrahedron: Asymmetry, 1999, 10, 4099
[3] Wakita H., Matsumoto K., Yoshiwara H., Hosono Y., Hayashi R., Nishiyama H., Nagase H., Tetrahedron, 1999, 55, 2449
[4] Collins P. W., Djuric S. W., Chem. Rev., 1993, 93(4), 1533
[5] Akasaka K., Ohrui H., Meguro H., Umestu T., Analytical Sciences, 1997, Suppl. 13, 461
[6] Hou D. L., Song H., Zhang B. Z., Wang E. S., Chinese Journal of Pharmaceuticals, 2015, 46(10), 1139
[7] Szabo T., Bodi J., Dalmadi G., Baloghne dr. Kardos K., Szeverenyi Z., Beraprost-eszter Eloallitasa Szelektiv Redukcioval, HU 227158, 2003
[8] Ohno K., Nagase H., Matsumoto K., Nishio S., 5,6,7-Trinor-4,8- inter-m-phenylene Prostaglandin I2 Derivatives Useful in Anti-ulcer, Hypotensive and Platelet Aggregation Inhibiting Compositions, US 4474802, 1984
[9] Wakita H., Yoshiwara H., Nishiyama H., Nagase H., Heterocycles, 2000, 53(5), 1085
[10] Sharma V., Batra H., Tuladhar S., Method of Producing Beraprost, US20120323025, 2012
[11] Clissold D. W., Matharu S. S., Benzoprostacyclin Intermediates and Methods for Their Preparation, WO2004005274, 2004
[12] Yiannikouros G. P., Kalaritis P., Gamage C. P., Arefyev D. V., Process for Preparing Synthetic Prostacyclins, WO2013040068, 2013
[13] Yong W. G., Hall H. K. Jr., Winstein S., J. Am. Chem. Soc., 1956, 78(17), 4338
[14] Ohno K., Nagase H., Hosono Y., Wakita H., Kawai K., Yashiwara H., Process of Producing 5,6,7-Trinor-4,8-inter-m-phenylene PGI2 Derivatives, US005202447, 1993
[15] Taber D. F., Amedio J. C. Jr., Raman K., J. Org. Chem., 1988, 53(13), 2984
[16] Mancuso A. J., Huang S. L., Swern D., J. Org. Chem., 1978, 43(12), 2480
[17] Omura K., Swern D., Tetrahedron, 1978, 34, 1651
[18] Masse C. E., Harbeson S. L., Tung R. D., Prostacyclin Derivatives, WO2011/003058, 2001 |